Neoadjuvant pembrolizumab achieved a 71% pCR rate in desmoplastic melanoma, surpassing expectations for neoadjuvant anti–PD-1 ...
Neoadjuvant chemotherapy (NACT) combined with pembrolizumab or with human epidermal growth factor receptor 2 (HER2)–directed agents, namely trastuzumab and pertuzumab, represents the standard of care ...
EYE PCR announces that its fixOflex endocapsular device has received CE Mark certification under the European Union Medical Device ...
Polymerase chain reaction (PCR) is a fundamental molecular biology tool that scientists use to amplify and analyze genetic material, such as DNA and RNA. PCR involves the enzymatic amplification of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results